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Natural immunity to tumours - theoretical predictions
and biological observations
Mammalian host defences can be broadly classified into two major systems viz adaptive
and non-adaptive immunity. Adaptive immunity is acquired and is mediated by B and
T lymphocytes. Non-adaptive immunity is mediated at least in part, by a small subset
of heterogeneous peripheral blood mononuclear cells, called 'null' cells, comprising
haemopoietic precursors and cells mediating natural killer (NK) activity and antibody-
dependent cellular cytotoxicity (ADCC). Much of the contemporary interest in natural
immunity arose during the 1970s from the study of anti-tumour immunity using
cultured tumour targets and lymphocytes, in short term cytotoxicity assays. Comparable
reactivity in both control and patients' blood pointed to a pervasive effector cell type
with broad target cell specificity.
NK cells are now recognised as a class of non-adherent, non-phagocytic,
spontaneously cytotoxic effectors which can efficiently lyse virus-infected cells,
neoplastic cells and notably, immature cell types of normal tissue provenance including
embryonic cells, bone marrow stem cells and a subpopulation of thymocytes. Their
activity against a restricted range of normal tissue targets suggests a physiological role
in the regulation ofcellular proliferation.
Characteristically, the lytic activity of NK cells is enhanced by interferons and
interleukin 2 (IL-2) (see Hoshino et al., 1984). Recently they have also been attributed
with several immunoregulatory properties including regulation of B cell differentiation
and antibody production as well as activities not requiring a lytic function viz antigen
presentation and the capacity to secrete a variety of cytokines.
In peripheral blood, NK cells are identifiable (though not exclusively) with large
granular lymphocytes (LGL), a small population of lymphoid cells characterised by a
reniform nucleus and azurophilic granules in the cytoplasm which can now be defined
by several monoclonal antibodies. Not all of these cells can induce lysis, though they
may possess other non-cytotoxic functions. Expansion of LGL in man occurs in a
group of rare disorders variously described as Ty-lymphocytosis, chronic Ty-cell
leukaemia or Ty-lymphoproliferative diseases. These diseases are heterogeneous in
terms of clinical course, cell membrane phenotype and immune functions (Newland et
al., 1984).
The lineage of NK cells has been the subject of considerable debate. On the one hand
they possess the characteristics of T lymphocytes (e.g. expression of T8 and TIO
antigens on a subset, and responsiveness to IL-2) while on the other they resemble
mononuclear phagocytes (e.g. expression of myelomonocytic antigens, capacity to
produce interleukin-l (IL-1), cytotoxicity against a wide range of tumour targets). It has
been proposed that LGL may even belong to a separate maturation lineage. In the
mouse, NK cells undergo gene rearrangement and express RNA of the T cell receptor
fl-chain genes, indicating a close association with the T cell lineage, at least for some
NK subsets (Yanagi et al., 1985). In man the evidence linking NK closely to T
lymphocytes has mostly been derived from comparisons of cultured LGL with T cells.
Since only a fraction of the entire LGL population can be induced to proliferate in vitro
the extent to which the attributes of the cultured population represent those of the large
majority of non-dividing LGL cannot presently be assessed.
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It has been claimed that natural killing is distinct from another recently described
lytic system - Lymphokine activated killing (LAK) - by the criteria of tissue
distribution, size and phenotype of the precursor and effector cells and the specificity of
killing (Grimm and Rosenberg, 1984). LAK effectors can lyse fresh solid tumours,
targets which are relatively refractory to lysis by NK cells (vide infra). The major
distinction from cytotoxic T lymphocytes, which phenotypically LAK cells resemble, is
that killing is not restricted by antigens encoded by the major histocompatibility
complex (MHC). In the National Cancer Institute, USA, there is currently interest in
the use of LAK cells for immunotherapy of certain solid tumours in man.
Klein (1983) has argued that since fresh NK cells and NK-like cells generated in
tissue culture have different phenotypes and target specificities, the term NK should be
confined to the former and that of AK (activated killing) used for the latter, irrespective
of origin. This distinction is operationally satisfactory since whether NK-like cells are
generated in mixed lymphocyte culture or by exposure to lymphokines, the resulting
effector populations share the common properties of MHC-non-restricted cyotoxicity
against a broad spectrum of targets (broader than that of fresh NK cells).
Despite the wide range of targets, by contrast with T cells, only a limited number of
specificities is thought to be involved in NK target recognition. This assumption is
largely derived from recent analyses of NK target specificity at the clonal level which
has provided only limited evidence of clonotypic distribution (Roberts and Moore,
1985). Recent suggestions favouring the transferrin receptor (present on all rapidly
dividing cells) as an acceptor molecule have found rather limited support, and no single
molecular change to account for the conversion from the NK-resistant to the NK-
sensitive state (or vice versa) has been described. In any event, this distinction is not
absolute and may be accounted for by differential sensitivity. Activated killer cells may
be capable of lysing targets with lower densities of NK target structures.
However, several investigators have questioned whether the NK phenomenon can be
delineated in terms of specific, interacting molecules postulating instead that the initial
effector: target cell interaction could depend on more diffuse biophysical properties of
cell membranes. Another hypothesis advocates that NK recognition of targets is guided
by 'negative' rather than 'positive' signals, i.e. by the absence rather than the
presence of cell surface molecules (Karre et al., 1984; and personal communication). In
this context it is noteworthy that a common feature of many NK targets is the complete
absence (or reduced expression) of antigens of the MHC. Accordingly, the MHC is
envisaged as the 'guidance system' which enables the host to dispose of elements which
are not recognisably 'self (negative identification). This process operates in certain
invertebrate species where it functions in the rejection of allogenic cells as well as in the
prevention of self-fertilisation. In vertebrates it may be regarded as a second line of
defence (not necessarily in the temporal sense) to be called upon when the first
(recognition by T cells of non-self in the context of self MHC) is either inappropriate,
or fails. This hypothesis thus envisages two functionally distinct, but complementary
systems of cell-mediated immune surveillance; one in which T cells are activated by the
recognition of 'altered' or 'non-self MHC products and another in which cells are
alerted by the absence or diminished expression of 'self MHC products. The
requirement for a defence system triggered by diminished expression of self MHC genes
is exemplified by the fact that embryonic cells and immature haemopoietic cells either
lack or express only very low levels of MHC products. These cells also have the
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normal compartments, they might escape physiological control, form ectopic tissues or
even become neoplastic. Also, host cells infected with transforming viruses capable of
'turning ofr MHC expression would escape T cells since foreignness would be
recognised only in the context of self MHC. Theoretically, tumour cells devoid of MHC
products would likewise be more vulnerable to NK.
Whatever the ultimate mechanism(s) by which NK cells recognise their targets it is
evident that they have a predilection for undifferentiated or immature targets of both
normal and malignant provenance. Given the heterogeneity of most neoplasms it might
be anticipated that only the least differentiated subpopulations of tumour cells would be
susceptible to NK attack. Indeed, the majority of solid tumours tested as whole (i.e.
unfractionated) populations constitute some of the more NK-resistant targets (though
resistance can be, to some extent, surmounted by activated killers). However, as with
non-immune forms of cell kill, the critical 'targets' are those which individually have
the capacity to repopulate the whole tumour if they are not destroyed - the so called
tumour 'stem' cells. Although the biology is yet far from clear, there is some evidence
to suggest that 'stem cells' and the 'clonogenic cells' detectable in in vitro clonogenic
assays are related. Typically in solid human tumours between 1 cell in 103 and 1 cell in
105 will be clonogenic, thus it cannot be ascertained from short-term cytotoxicity
studies utilising whole populations as targets, whether this critical cellular compartment
is susceptible to NK lysis. Such experiments are technically difficult to perform, but it is
significant that where this question has been addressed (in human adult leukaemias)
NK cells have been shown to significantly inhibit clonogenesis (Beran et al., 1983), an
activity which may have biological relevance.
Preoccupation with the mechanistic aspects of NK cells has tended to detract from
the elucidation of their physiological role in the organism, and there is an increasing
awareness that this balance should be redressed. However, an understanding of the
biology of NK cells must involve an appreciation of their heterogeneity, tissue
distribution (and that of their precursors) at the anatomical and microanatomical levels,
activation status, capacity for mobilisation, etc. Presently our knowledge of these areas
is incomplete. The regulation of extravasation of LGL and their fate in tissues, for
instance, have yet to be elucidated. In functional terms NK activity is greatest in blood
and spleen but relatively poor or indetectable in lymph node, thymus, thoracic duct and
bone marrow. Immunohistochemical and radiolabelling experiments in the rat, however,
have revealed the lungs and intestines as well as blood and spleen as the major sites of
LGL (Ward et al., 1983). There is, furthermore, in vitro evidence that LGL, which have
a uropod, suggestive of a motile, polarised cell may migrate promptly in response to
various stimuli (Bottazzi et al., 1985). In rat allografts LGL infiltration has been
reported to occur early and to precede the entry of conventional lymphocytes
(Nemlander et al., 1983), and in man cells expressing NK-like activity are detectable at
sites of delayed hypersensitivity (Tartof et al., 1984). Thus, the population as a whole
appears to be mobilisable, a property which would be important particularly for
defence against infectious agents, and possibly against incipient tumour cells as well.
There seems to be little doubt that by functional and immunohistological criteria NK
cells are few and far between in established human solid tumours. Provisionally, their
'exclusion' would appear in part, to be selective, since intratumour populations of
other leucocytes and their subsets, especially T cells, are frequently well represented. A
paucity of NK cells in situ might not be inimical to an anti-tumour role if they had a
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other effector cell types. However, as cytotoxic effectors, a function which requires
intimate target cell contact, their role in situ is likely to be minimal or non-existent. In
man at least, NK cells detectable at the tumour site show depressed lytic capability and
are unable to recycle for multiple events. Theoretically, the most likely site of tumour
destruction in vivo by NK cells, would be in the circulation where their activity is
greatest, but there is little direct evidence for this man. As already stated, lymph nodes,
to which the majority of epithelial cancers metastasize, are generally low in NK activity
though there is some evidence that this may be augmented by local immune
stimulation. This observation lends further credence to the idea that if NK cells are
active against tumours at all, blood-borne metastases are the most likely targets. It
would follow from these considerations that estimates of patient NK activity based on
peripheral blood have few, if any, implications for the in situ NK responses to a given
neoplasm. This is especially so if, as is frequently the case, the 'target' and the type of
assay have little relevance to the disease under study.
Although purified and cloned murine NK cells undoubtedly have some therapeutic
efficacy against tumours in vivo, this appears to be largely limited to the artificial
inception of neoplastic growth by NK-sensitive cells following the transplantation of
graded intravenous inocula (Warner and Dennert, 1982; Barlozzari et al., 1985), (where
incidentally, the 'stem cell' compartment of the neoplasm is likely to comprise a
substantial proportion of the whole tumour population). An effect of NK cells on de
novo tumour formation has been much less convincing, yet it is against incipient
malignancy that NK cells have been primarily implicated. Data purporting to support
the immunosurveillance theory have been obtained in mice with different levels of NK
activity, or in models where the hosts were treated with agents supposedly exerting a
selective effect on NK function, but in which differences in immune response other than
NK activity were difficult to exclude.
However, recent studies based on several murine and human tumours in variants of
athymic nude mice with divergent levels of NK activity failed to disclose a correlation
between the latter property and tumour growth (Fodstad et al., 1984). Moreover,
pertinent to the discussion on metastasis above, low NK activity in mice, was not
necessarily associated with increased lung colony formation by human or murine
melanoma cells, nor was there invariably any correlation between host NK activity and
the rate of elimination of radiolabelled tumour cells from liver, lungs or spleen. Thus,
for some investigators at least, the experimental data have not borne out the theoretical
predictions.
However, while the evidence for NK cells in the regulation of tumour growth remains
equivocal, their involvement in acute bone marow transplant rejection in lethally
irradiated mice now appears to have been established beyond doubt (Warner and
Dennert, 1985). The exquisite specificity of the in vivo reaction which is controlled by
antigenic determinants encoded in or near the H-2 gene complex is not reflected in the
in vitro cytotoxicity assays. In fact, several experimental approaches indicate that
specific serum antibody present in responder strains of mice, directs NK cells in an
antibody-dependent cytolytic and/or cytostatic reaction (ADCC) resulting in marrow
graft rejection. This recent disclosure has clarified a mechanism for the recognition and
rejection of allogeneic bone marrow which had remained obscure for many years and is
futhermore the first in vivo demonstration of the long familiar in vitro ADCC reaction.
That some of the susceptible normal cell types (such as bone marrow stem cells and a
subpopulation of thymocytes) are to be found in tissue sites where the local NK activityEDITORIAL 151
is minimal or non-existent, suggests that one of the functions of NK cells is to prevent
trespass beyond normal physiological environments. Stem cell populations under an
oncogenic influence undergoing expansion into 'forbidden clones' might thus be prime
targets for NK cells once outside their normal tissue compartments. Since NK
precursors may be found in both bone marrow and thymus and may be 'activated' by
certain stimuli, NK cells may be expected to exert a local influence as well. This model
might reasonably be extended to include the stem cells of tissues other than bone
marrow, but has no implication for the importance of such a mechanism relative to
others in controlling the emergence of neoplastic clones. The 'escape' from host
restraint is a multifactorial process involving the breakdown of homeostatic mechanisms
and evasion by failure of immunological recognition. Data derived from the study of
murine and human leukaemias encourage the view that NK cells may have a role in the
surveillance of lymphoproliferative malignancies but the extent of their involvement,
and whether similar mechanisms are operative against tumours arising in other sites is
debatable. The gap between theoretical prediction and experimental realisation thus
remains.
Paterson Laboratories, M. Moore
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